Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2026-01-13 @ 5:36 PM
Study NCT ID:
NCT04620200
Status:
COMPLETED
Last Update Posted:
2025-08-11
First Post:
2020-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery
Sponsor:
The Netherlands Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-20
First Submit QC Date:
None
Study First Post Date:
2020-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-06
Last Update Post Date:
2025-08-11
Last Update Post Date Type:
ACTUAL